CIK: 0001263508 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $18,379,749 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seagen Inc. | 46,913,769 | $9,498,631 | 51.7% | $195.69 | — | COM | 81181C104 |
| INCY | Incyte Corporation | 36,175,400 | $2,614,396 | 14.2% | $72.80 | +7.5% | COM | 45337C102 |
| ONC | BeiGene, Ltd. | 11,668,897 | $2,514,997 | 13.7% | $136.93 | — | SPONSORED ADR | 07725L102 |
| ACAD | ACADIA Pharmaceuticals Inc. | 41,938,486 | $789,282 | 4.3% | $18.86 | +1.0% | COM | 004225108 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,545,113 | $374,319 | 2.0% | $104.60 | +160.5% | COM | 558868105 |
| BMRN | BioMarin Pharmaceutical Inc. | 3,810,248 | $370,509 | 2.0% | $81.02 | +27.9% | COM | 09061G101 |
| IMCR | Immunocore Holdings plc | 2,520,731 | $124,625 | 0.7% | $42.57 | — | ADS | 45258D105 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 6,498,267 | $115,929 | 0.6% | $23.52 | +6.8% | COM | 76243J105 |
| KOD | Kodiak Sciences Inc. | 17,310,490 | $107,325 | 0.6% | $30.30 | -76.9% | COM | 50015M109 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 12,710,818 | $106,008 | 0.6% | $6.35 | +51.5% | COM | 09058V103 |
| ARGX | argenx SE | 280,159 | $104,382 | 0.6% | $79.01 | — | SPONSORED ADR | 04016X101 |
| — | Akero Therapeutics, Inc. | 2,368,378 | $90,614 | 0.5% | $33.89 | — | COM | 00973Y108 |
| KYMR | Kymera Therapeutics, Inc. | 2,879,825 | $85,329 | 0.5% | $33.35 | -3.3% | COM | 501575104 |
| REPL | Replimune Group, Inc. | 4,578,280 | $80,852 | 0.4% | $19.30 | +23.2% | COM | 76029N106 |
| ABCL | AbCellera Biologics Inc. | 10,450,180 | $78,794 | 0.4% | $45.73 | -80.1% | COM | 00288U106 |
| — | SpringWorks Therapeutics, Inc. | 2,753,502 | $70,875 | 0.4% | $25.89 | — | COM | 85205L107 |
| TRDA | Entrada Therapeutics, Inc. | 4,865,819 | $70,554 | 0.4% | $16.96 | — | COM | 29384C108 |
| BMEA | Biomea Fusion, Inc. | 2,108,949 | $65,399 | 0.4% | $8.56 | +45.1% | COM | 09077A106 |
| RVMD | Revolution Medicines, Inc. | 2,691,493 | $58,298 | 0.3% | $26.29 | -6.3% | COM | 76155X100 |
| PRLD | Prelude Therapeutics Inc. | 10,123,824 | $57,706 | 0.3% | $28.24 | -78.4% | COM | 74065P101 |
| — | Mirati Therapeutics, Inc. | 1,409,784 | $52,416 | 0.3% | $22.85 | — | COM | 60468T105 |
| — | FibroGen, Inc. | 2,637,384 | $49,214 | 0.3% | $16.38 | — | COM | 31572Q808 |
| CERS | Cerus Corporation | 16,067,558 | $47,721 | 0.3% | $4.69 | -35.8% | COM | 157085101 |
| — | IGM Biosciences, Inc. | 3,156,656 | $43,372 | 0.2% | $17.75 | — | COM | 449585108 |
| — | Aerovate Therapeutics, Inc. | 1,963,479 | $39,603 | 0.2% | $21.15 | — | COM | 008064107 |
| IMTX | Immatics N.V. | 5,187,081 | $35,791 | 0.2% | $10.97 | -25.4% | SHS | N44445109 |
| ROIV | Roivant Sciences Ltd. | 4,777,430 | $35,257 | 0.2% | $7.83 | +5.1% | SHS | G76279101 |
| NRIX | Nurix Therapeutics, Inc. | 3,882,125 | $34,473 | 0.2% | $22.27 | -53.2% | COM | 67080M103 |
| — | Chinook Therapeutics, Inc. | 1,455,202 | $33,688 | 0.2% | $14.83 | — | COM | 16961L106 |
| — | Kiniksa Pharmaceuticals, Ltd. | 2,799,577 | $30,123 | 0.2% | $17.35 | — | COM CL A | G5269C101 |
| — | DICE Therapeutics, Inc. | 1,035,786 | $29,675 | 0.2% | $31.65 | — | COM | 23345J104 |
| XENE | Xenon Pharmaceuticals Inc. | 751,639 | $26,901 | 0.1% | $13.09 | +182.3% | COM | 98420N105 |
| — | 2seventy bio, Inc. | 2,497,526 | $25,475 | 0.1% | $18.72 | — | COM | 901384107 |
| DNLI | Denali Therapeutics Inc. | 1,088,738 | $25,085 | 0.1% | $27.40 | +0.5% | COM | 24823R105 |
| — | DBV Technologies S.A. | 14,614,264 | $24,698 | 0.1% | $19.06 | — | SPONSORED ADR | 23306J101 |
| KRYS | Krystal Biotech, Inc. | 302,716 | $24,235 | 0.1% | $34.45 | +128.1% | COM | 501147102 |
| — | Verve Therapeutics, Inc. | 1,416,530 | $20,426 | 0.1% | $60.25 | — | COM | 92539P101 |
| RARE | Ultragenyx Pharmaceutical Inc. | 470,974 | $18,886 | 0.1% | $115.41 | -62.8% | COM | 90400D108 |
| BCYC | Bicycle Therapeutics plc | 843,814 | $17,948 | 0.1% | $23.26 | — | SPONSORED ADS | 088786108 |
| STOK | Stoke Therapeutics, Inc. | 2,115,416 | $17,621 | 0.1% | $10.71 | -15.8% | COM | 86150R107 |
| ANAB | AnaptysBio, Inc. | 775,924 | $16,884 | 0.1% | $27.04 | -10.1% | COM | 032724106 |
| RNAM | Avidity Biosciences, Inc. | 1,004,051 | $15,412 | 0.1% | $18.93 | +16.2% | COM | 05370A108 |
| — | Blueprint Medicines Corporation | 333,665 | $15,012 | 0.1% | $44.99 | — | COM | 09627Y109 |
| SPRY | ARS Pharmaceuticals, Inc. | 2,006,451 | $13,062 | 0.1% | $6.49 | +18.4% | COM | 82835W108 |
| PACB | Pacific Biosciences of California, Inc. | 1,127,782 | $13,060 | 0.1% | $15.59 | -36.2% | COM | 69404D108 |
| PRME | Prime Medicine, Inc. | 1,028,466 | $12,650 | 0.1% | $18.06 | -9.8% | COM | 74168J101 |
| HRTX | Heron Therapeutics, Inc. | 8,131,678 | $12,279 | 0.1% | $17.29 | -85.5% | COM | 427746102 |
| — | Invitae Corporation | 8,881,104 | $11,989 | 0.1% | $24.10 | — | COM | 46185L103 |
| IDYA | IDEAYA Biosciences, Inc. | 832,769 | $11,434 | 0.1% | $12.99 | +28.3% | COM | 45166A102 |
| CABA | Cabaletta Bio, Inc. | 1,344,000 | $11,115 | 0.1% | $7.63 | +22.6% | COM | 12674W109 |
| SMMT | Summit Therapeutics Inc. | 6,304,705 | $11,033 | 0.1% | $2.44 | +11.8% | COM | 86627T108 |
| ADAPY | Adaptimmune Therapeutics plc | 9,830,877 | $10,716 | 0.1% | $5.77 | — | SPONSORED ADR | 00653A107 |
| OPTEY | Opthea Limited | 2,691,391 | $10,631 | 0.1% | $11.12 | — | SPONSORED ADS | 68386J208 |
| — | Verastem, Inc. | 25,521,447 | $10,597 | 0.1% | $2.39 | — | COM | 92337C104 |
| FATE | Fate Therapeutics, Inc. | 1,671,717 | $9,529 | 0.1% | $8.98 | -32.8% | COM | 31189P102 |
| — | POINT Biopharma Global Inc. | 1,169,103 | $8,499 | 0.0% | $7.73 | — | COM | 730541109 |
| — | bluebird bio, Inc. | 2,499,715 | $7,949 | 0.0% | $22.65 | — | COM | 09609G100 |
| ALLO | Allogene Therapeutics, Inc. | 1,576,901 | $7,790 | 0.0% | $6.41 | 0.0% | COM | 019770106 |
| — | Mersana Therapeutics, Inc. | 1,886,115 | $7,752 | 0.0% | $4.11 | — | COM | 59045L106 |
| WHWK | Aadi Bioscience, Inc. | 989,928 | $7,167 | 0.0% | $13.14 | -18.7% | COM | 00032Q104 |
| SERA | Sera Prognostics, Inc. | 1,789,000 | $6,852 | 0.0% | $3.50 | -25.0% | CLASS A COM | 81749D107 |
| GERN | Geron Corporation | 3,061,224 | $6,643 | 0.0% | $2.84 | 0.0% | COM | 374163103 |
| SANA | Sana Biotechnology, Inc. | 2,000,000 | $6,540 | 0.0% | $4.00 | 0.0% | SHS | 799566104 |
| — | Aravive, Inc. | 3,261,224 | $6,522 | 0.0% | $1.32 | — | COM | 03890D108 |
| MGNX | MacroGenics, Inc. | 892,579 | $6,400 | 0.0% | $14.35 | -58.0% | COM | 556099109 |
| ALEC | Alector, Inc. | 964,851 | $5,972 | 0.0% | $12.71 | -36.0% | COM | 014442107 |
| — | Athira Pharma, Inc. | 2,350,355 | $5,876 | 0.0% | $8.27 | — | COM | 04746L104 |
| INSM | Insmed Incorporated | 343,000 | $5,848 | 0.0% | $19.59 | -0.8% | COM PAR $.01 | 457669307 |
| TCRX | TScan Therapeutics, Inc. | 2,784,792 | $5,848 | 0.0% | $6.08 | -61.0% | COM | 89854M101 |
| NTRA | Natera, Inc. | 100,000 | $5,552 | 0.0% | $37.02 | +29.6% | COM | 632307104 |
| CMPX | Compass Therapeutics, Inc. | 1,557,630 | $5,093 | 0.0% | $3.99 | -1.6% | COM | 20454B104 |
| — | Affimed N.V. | 6,596,830 | $4,919 | 0.0% | $4.50 | — | COM | N01045108 |
| RLAY | Relay Therapeutics, Inc. | 284,000 | $4,677 | 0.0% | $17.93 | 0.0% | COM | 75943R102 |
| — | Atreca, Inc. | 3,532,760 | $4,027 | 0.0% | $18.84 | — | CL A COM | 04965G109 |
| IPSC | Century Therapeutics, Inc. | 1,149,340 | $3,988 | 0.0% | $9.79 | -55.1% | COM | 15673T100 |
| — | Talis Biomedical Corporation | 7,624,835 | $3,736 | 0.0% | $12.85 | — | COM | 87424L108 |
| DSGN | Design Therapeutics, Inc. | 626,884 | $3,617 | 0.0% | $31.14 | -76.0% | COM | 25056L103 |
| — | Instil Bio, Inc. | 5,273,789 | $3,485 | 0.0% | $18.68 | — | COM | 45783C101 |
| XNCR | Xencor, Inc. | 123,127 | $3,434 | 0.0% | $27.96 | +10.2% | COM | 98401F105 |
| — | Vor Biopharma Inc. | 633,848 | $3,410 | 0.0% | $4.75 | — | COM | 929033108 |
| EWTX | Edgewise Therapeutics, Inc. | 500,000 | $3,335 | 0.0% | $32.43 | -71.4% | COM | 28036F105 |
| TNGX | Tango Therapeutics, Inc. | 750,000 | $2,963 | 0.0% | $11.99 | -51.6% | COM | 87583X109 |
| GLUE | Monte Rosa Therapeutics, Inc. | 375,095 | $2,922 | 0.0% | $6.95 | 0.0% | COM | 61225M102 |
| — | Neoleukin Therapeutics, Inc. | 3,821,740 | $2,675 | 0.0% | $3.87 | — | COM | 64049K104 |
| VERA | Vera Therapeutics, Inc. | 333,333 | $2,587 | 0.0% | $21.52 | -64.1% | CL A | 92337R101 |
| — | HOOKIPA Pharma Inc. | 3,475,535 | $2,558 | 0.0% | $2.72 | — | COM | 43906K100 |
| — | Leap Therapeutics, Inc. | 7,425,570 | $2,525 | 0.0% | $0.40 | — | COM | 52187K101 |
| — | Achilles Therapeutics plc | 2,591,366 | $2,481 | 0.0% | $16.55 | — | SPONSORED ADS | 00449L102 |
| — | Atara Biotherapeutics, Inc. | 744,186 | $2,158 | 0.0% | $7.79 | — | COM | 046513107 |
| — | iTeos Therapeutics, Inc. | 150,346 | $2,046 | 0.0% | $24.67 | — | COM | 46565G104 |
| — | Veru Inc. | 1,609,579 | $1,867 | 0.0% | $11.52 | — | COM | 92536C103 |
| PCVX | Vaxcyte, Inc. | 48,885 | $1,832 | 0.0% | $39.24 | +8.1% | COM | 92243G108 |
| — | Aligos Therapeutics, Inc. | 2,076,400 | $1,815 | 0.0% | $24.92 | — | COM | 01626L105 |
| PMVP | PMV Pharmaceuticals, Inc. | 322,024 | $1,536 | 0.0% | $14.45 | -51.3% | COM | 69353Y103 |
| — | Praxis Precision Medicines, Inc. | 1,879,915 | $1,521 | 0.0% | $2.34 | — | COM | 74006W108 |
| NKTX | Nkarta, Inc. | 400,000 | $1,420 | 0.0% | $13.12 | -63.9% | COM | 65487U108 |
| KALA | Kala Pharmaceuticals, Inc. | 76,813 | $1,156 | 0.0% | $7.92 | +120.3% | COM | 483119202 |
| — | TCR2 Therapeutics Inc. | 753,064 | $1,130 | 0.0% | $8.48 | — | COM | 87808K106 |
| — | Aeglea BioTherapeutics, Inc. | 3,410,106 | $989 | 0.0% | $7.84 | — | COM | 00773J103 |
| TARA | Protara Therapeutics, Inc. | 199,671 | $625 | 0.0% | $30.96 | -89.3% | COM STK | 74365U107 |
| — | Genetron Holdings Limited | 455,306 | $478 | 0.0% | $13.55 | — | ADS | 37186H100 |
| FHTX | Foghorn Therapeutics Inc. | 45,027 | $279 | 0.0% | $14.37 | -54.5% | COM | 344174107 |
| — | Vincerx Pharma, Inc. | 241,379 | $251 | 0.0% | $16.17 | — | COM | 92731L106 |
| SRZNW | Surrozen, Inc. | 833,333 | $83 | 0.0% | $1.14 | — | W EXP 8/11/2026 | 86889P117 |
| — | Bellicum Pharmaceuticals, Inc. | 249,123 | $82 | 0.0% | $4.71 | — | COM | 079481404 |